- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Evoq Remedies Limited has announced a board meeting to approve an Extraordinary General Meeting (EGM) via video conferencing. The company proposes to increase its authorised share capital from Rs. 25 Cr to Rs. 42 Cr to support future growth. It plans to issue up to 1 crore equity shares to non-promoter shareholders of Spazio Formulations Limited as a non-cash consideration against acquiring 50.36% stake in Spazio. Additionally, up to 63.36 lakh equity shares will be issued to promoter Bhumishth N Patel against acquiring 71.95% stake in Poshan Nutriwell Private Limited, also as a swap. Both issues are at Rs. 10 per share, supported by a registered valuer’s report. The company will amend its Memorandum of Association to reflect these changes and expand its business into agriculture and agro-based products. There will be no change in management control following these transactions. The equity shares issued will be fully paid-up and subject to listing and lock-in requirements as per applicable laws.